M. Berrey
Chief Tech/Sci/R&D Officer chez INTERCEPT PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Profil
M.
Michelle Berrey is currently the Director at The North Carolina Biotechnology Center, Director at Noveome Biotherapeutics, Inc., Director at Virion Therapeutics LLC, Independent Director at Ocean Biomedical, Inc. (United States), Independent Director at Ocean Biomedical, Inc., and Chief Medical Officer & President-Research at Intercept Pharmaceuticals, Inc. She previously held positions as President, Chief Executive & Medical Officer at Chimerix, Inc., Chief Medical Officer & VP-Clinical Development at Pharmasset, Inc., and VP-Viral Diseases & Clinical Pharmacology at GSK Plc.
Berrey received her undergraduate and graduate degrees from Emory University and her doctorate from Georgia Health Sciences University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCEAN BIOMEDICAL, INC.
-.--% | 03/08/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de M. Berrey
| Sociétés | Poste | Début |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 09/06/2021 |
| OCEAN BIOMEDICAL, INC. | Director/Board Member | 14/02/2023 |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Director/Board Member | - |
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Director/Board Member | 22/10/2020 |
Ocean Biomedical, Inc. (United States)
 Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Director/Board Member | 01/03/2021 |
Virion Therapeutics LLC
 Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Director/Board Member | 12/07/2021 |
Anciens postes connus de M. Berrey
| Sociétés | Poste | Fin |
|---|---|---|
| CHIMERIX, INC. | Chief Executive Officer | 05/02/2019 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 13/01/2012 |
| GSK PLC | Corporate Officer/Principal | 01/01/2007 |
Formation de M. Berrey
| Emory University | Graduate Degree |
| Georgia Health Sciences University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| OCEAN BIOMEDICAL, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Technology Services |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Health Technology |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Health Technology |
Ocean Biomedical, Inc. (United States)
Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Commercial Services |
